What are the compliance obligations for clients under REACH Annex XIV and Annex XVII?
For Annex XIV, the substances must be authorised for the specific use. Articles using the authorised substance should be included as a use for that substance when manufactured in the EU. If the use is not authorised and the product is manufactured in EU, the article would not be allowed on the market. Non-EU based companies are currently exempt from the need to meet the authorisation requirements, but this is being reviewed.
For Annex XVII, the substance and articles containing the substance are restricted from being placed on the market (unless a specific exemption is allowed).